Is There a Risk of Yellow Fever Virus Transmission in South Asian Countries with Hyperendemic Dengue?

Overview

Journal Biomed Res Int

Publisher Wiley

Specialties Biomedical Engineering
Biotechnology
General Medicine

Date 2013 Dec 25

PMID 24367789

Citations 9

Authors

Suneth B Agampodi

Kolitha Wickramage

Affiliations

Soon will be listed here.

Abstract

The fact that yellow fever (YF) has never occurred in Asia remains an "unsolved mystery" in global health. Most countries in Asia with high Aedes aegypti mosquito density are considered "receptive" for YF transmission. Recently, health officials in Sri Lanka issued a public health alert on the potential spread of YF from a migrant group from West Africa. We performed an extensive review of literature pertaining to the risk of YF in Sri Lanka/South Asian region to understand the probability of actual risk and assist health authorities to form evidence informed public health policies/practices. Published data from epidemiological, historical, biological, molecular, and mathematical models were harnessed to assess the risk of YF in Asia. Using this data we examine a number of theories proposed to explain lack of YF in Asia. Considering the evidence available, we conclude that the probable risk of local transmission of YF is extremely low in Sri Lanka and for other South Asian countries despite a high Aedes aegypti density and associated dengue burden. This does not however exclude the future possibility of transmission in Asia, especially considering the rapid influx travelers from endemic areas, as we report, arriving in Sri Lanka.

Citing Articles

Potential role of heterologous flavivirus immunity in preventing urban transmission of yellow fever virus.

Shinde D, Plante J, Scharton D, Mitchell B, Walker J, Azar S Nat Commun. 2024; 15(1):9728.

PMID: 39523371 PMC: 11551182. DOI: 10.1038/s41467-024-54146-9.

Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model.

Shinde D, Walker J, Reyna R, Scharton D, Mitchell B, Dulaney E Viruses. 2024; 16(6).

PMID: 38932129 PMC: 11209131. DOI: 10.3390/v16060836.

Yellow Fever: Roles of Animal Models and Arthropod Vector Studies in Understanding Epidemic Emergence.

Shinde D, Plante J, Plante K, Weaver S Microorganisms. 2022; 10(8).

PMID: 36013996 PMC: 9412558. DOI: 10.3390/microorganisms10081578.

The Absence of Yellow Fever in Asia: History, Hypotheses, Vector Dispersal, Possibility of YF in Asia, and Other Enigmas.

Kuno G Viruses. 2020; 12(12).

PMID: 33255615 PMC: 7759908. DOI: 10.3390/v12121349.

Yellow Fever-More a Policy and Planning Problem than a Biological One.

Calisher C, Woodall J Emerg Infect Dis. 2016; 22(10):1859-60.

PMID: 27479749 PMC: 5038394. DOI: 10.3201/eid2210.160875.

References

Messer W, Vitarana U, Sivananthan K, Elvtigala J, Preethimala L, Ramesh R . Epidemiology of dengue in Sri Lanka before and after the emergence of epidemic dengue hemorrhagic fever. Am J Trop Med Hyg. 2002; 66(6):765-73. DOI: 10.4269/ajtmh.2002.66.765. View

Barkhash A, Perelygin A, Babenko V, Myasnikova N, Pilipenko P, Romaschenko A . Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J Infect Dis. 2010; 202(12):1813-8. DOI: 10.1086/657418. View

Juliano S, Lounibos L, OMeara G . A field test for competitive effects of Aedes albopictus on A. aegypti in South Florida: differences between sites of coexistence and exclusion?. Oecologia. 2004; 139(4):583-93. PMC: 1906877. DOI: 10.1007/s00442-004-1532-4. View

Rezza G . Aedes albopictus and the reemergence of Dengue. BMC Public Health. 2012; 12:72. PMC: 3398301. DOI: 10.1186/1471-2458-12-72. View

Tapia-Conyer R, Betancourt-Cravioto M, Mendez-Galvan J . Dengue: an escalating public health problem in Latin America. Paediatr Int Child Health. 2012; 32 Suppl 1:14-7. PMC: 3381443. DOI: 10.1179/2046904712Z.00000000046. View

Mongkolsapaya J, Dejnirattisai W, Xu X, Vasanawathana S, Tangthawornchaikul N, Chairunsri A . Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med. 2003; 9(7):921-7. DOI: 10.1038/nm887. View

Aseffa A . Viral diseases in Ethiopia: a review. East Afr Med J. 1993; 70(10):624-6. View

Crill W, Chang G . Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol. 2004; 78(24):13975-86. PMC: 533943. DOI: 10.1128/JVI.78.24.13975-13986.2004. View

Chow V, Chan Y, Yong R, Lee K, Lim L, Chung Y . Monitoring of dengue viruses in field-caught Aedes aegypti and Aedes albopictus mosquitoes by a type-specific polymerase chain reaction and cycle sequencing. Am J Trop Med Hyg. 1998; 58(5):578-86. DOI: 10.4269/ajtmh.1998.58.578. View

10.

Kurukumbi M, Wali J, Broor S, Aggarwal P, Seth P, Handa R . Seroepidemiology and active surveillance of dengue fever/dengue haemorrhagic fever in Delhi. Indian J Med Sci. 2001; 55(3):149-56. View

11.

Lorenz L, Beaty B, AITKEN T, Wallis G, Tabachnick W . The effect of colonization upon aedes aegypti susceptibility to oral infection with yellow fever virus. Am J Trop Med Hyg. 1984; 33(4):690-4. DOI: 10.4269/ajtmh.1984.33.690. View

12.

Shellam G, Sangster M, Urosevic N . Genetic control of host resistance to flavivirus infection in animals. Rev Sci Tech. 1998; 17(1):231-48. DOI: 10.20506/rst.17.1.1083. View

13.

Deng Y, Dai J, Ji G, Jiang T, Wang H, Yang H . A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein. PLoS One. 2011; 6(1):e16059. PMC: 3019176. DOI: 10.1371/journal.pone.0016059. View

14.

Jupp P, Kemp A . Laboratory vector competence experiments with yellow fever virus and five South African mosquito species including Aedes aegypti. Trans R Soc Trop Med Hyg. 2002; 96(5):493-8. DOI: 10.1016/s0035-9203(02)90417-7. View

15.

Jentes E, Poumerol G, Gershman M, Hill D, Lemarchand J, Lewis R . The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis. 2011; 11(8):622-32. DOI: 10.1016/S1473-3099(11)70147-5. View

16.

Miller B, Monath T, Tabachnick W, Ezike V . Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol. 1989; 40(4):396-9. View

17.

Amaku M, Coutinho F, Massad E . Why dengue and yellow fever coexist in some areas of the world and not in others?. Biosystems. 2011; 106(2-3):111-20. DOI: 10.1016/j.biosystems.2011.07.004. View

18.

Okamoto Y, Kurane I, Leporati A, Ennis F . Definition of the region on NS3 which contains multiple epitopes recognized by dengue virus serotype-cross-reactive and flavivirus-cross-reactive, HLA-DPw2-restricted CD4+ T cell clones. J Gen Virol. 1998; 79 ( Pt 4):697-704. DOI: 10.1099/0022-1317-79-4-697. View

19.

Coffey L, Mertens E, Brehin A, Fernandez-Garcia M, Amara A, Despres P . Human genetic determinants of dengue virus susceptibility. Microbes Infect. 2009; 11(2):143-56. DOI: 10.1016/j.micinf.2008.12.006. View

20.

Tripet F, Lounibos L, Robbins D, Moran J, Nishimura N, Blosser E . Competitive reduction by satyrization? Evidence for interspecific mating in nature and asymmetric reproductive competition between invasive mosquito vectors. Am J Trop Med Hyg. 2011; 85(2):265-70. PMC: 3144823. DOI: 10.4269/ajtmh.2011.10-0677. View